What Neuronetics STIM management is focused on executing Q1 2026 Profit Exceeds Views How Alliance Ent AENT adapts when conditions change 095 20260506 How Exact EXAS manages tail risk exposure Q4 2025 Earnings Underperform VEON Ltd VEON Edges Lower as Shares Navigate Key Support and Resistance Levels Trump Asks Supreme Court to Pause TikTok Ban Potential Shift in Regulatory Landscape SMSI Q1 2026 Earnings NarrowerThanExpected Loss Drives Sharp Share Advance US Government Stake Speculation Intensifies Traders Eye IonQ Micron and Anduril as Next Candidates Gain Therapeutics Inc GANX Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Progress Continues SNPS Q1 2026 Earnings EPS Beats Estimates by 414 Amid Mixed Market Response HERE Q4 2025 Earnings Massive EPS Surprise of 115368 on BottomLine Beat NTAP Q1 2026 Earnings EPS Beats Estimates by 509 Stock Surges Over 22 AURA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline ACON Q1 2026 Earnings EPS Surpasses Estimates with 152 Positive Surprise Visa V Q1 2026 Earnings EPS Beat Drives Modest Share Gains